Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Clinical trial NCT00337454 · COMPLETED

Trial details

NCT number: NCT00337454
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia

Start date: 2005-07-01
Primary completion: 2007-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.